C. Ahern

发表

Risk-Specific Optimal Cancer Screening Schedules: An Application to Breast Cancer Early Detection

C. Ahern, Yi Cheng, Yu Shen, 2011, Statistics in biosciences.

Cost-effectiveness of alternative strategies for integrating MRI into breast cancer screening for women at high risk

G. Parmigiani, C. Ahern, Y. Shih, 2014, British Journal of Cancer.

Statistical modeling in the optimization of breast cancer screening schedules

C. Ahern, 2009 .

LONG-TERM OUTCOME OF CENTRALLY LOCATED LOW-GRADE GLIOMA IN CHILDREN

W. Whitehead, C. Ahern, C. Lau, 2014 .

Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: A children's oncology group study

R. Norris, C. Ahern, P. Adamson, 2014, Pediatric blood & cancer.

A Phase I Study of Cixutumumab (IMC-A12) in Combination with Temsirolimus (CCI-779) in Children with Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Report

Helen X. Chen, P. Houghton, C. Ahern, 2014, Clinical Cancer Research.

A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: A children's oncology group phase 1 consortium study

R. Gilbertson, C. Ahern, J. Reid, 2013, Pediatric blood & cancer.

Pediatric Phase I Trial and Pharmacokinetic Study of MLN8237, an Investigational Oral Selective Small-Molecule Inhibitor of Aurora Kinase A: A Children's Oncology Group Phase I Consortium Study

J. Maris, D. Teachey, C. Ahern, 2012, Clinical Cancer Research.

Efficacy of crizotinib in children with relapsed/refractory ALK-driven tumors including anaplastic large cell lymphoma and neuroblastoma: A Children's Oncology Group phase I consortium study.

M. Lim, C. Ahern, P. Adamson, 2012 .

Obesity does not increase complications following pancreatic surgery.

C. Ahern, N. Petersen, W. Fisher, 2011, The Journal of surgical research.

A phase I trial of MK‐2206 in children with refractory malignancies: A Children's Oncology Group study

P. Houghton, C. Ahern, L. Doyle, 2014, Pediatric blood & cancer.

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.

J. Maris, M. Lim, K. Wilner, 2013, The Lancet. Oncology.

A phase I trial and viral clearance study of reovirus (Reolysin) in children with relapsed or refractory extra‐cranial solid tumors: A Children's Oncology Group Phase I Consortium report

C. Ahern, T. Cripe, B. Weigel, 2015, Pediatric blood & cancer.

Down-regulation of ZIP4 by RNA Interference Inhibits Pancreatic Cancer Growth and Increases the Survival of Nude Mice with Pancreatic Cancer Xenografts

C. Ahern, W. Fisher, F. Brunicardi, 2009, Clinical Cancer Research.

Long‐term outcome of centrally located low‐grade glioma in children

W. Whitehead, C. Ahern, C. Lau, 2013, Cancer.

A Phase I Trial of Imetelstat in Children with Refractory or Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Study (ADVL1112)

C. Ahern, J. Reid, M. Fouladi, 2013, Clinical Cancer Research.

Tolerability and pharmacokinetic profile of a sunitinib powder formulation in pediatric patients with refractory solid tumors: a Children’s Oncology Group study

S. Baruchel, C. Ahern, P. Adamson, 2012, Cancer Chemotherapy and Pharmacology.

Phase I and Pharmacokinetic Study of Sunitinib in Pediatric Patients with Refractory Solid Tumors: A Children's Oncology Group Study

S. Baruchel, C. Ahern, P. Adamson, 2011, Clinical Cancer Research.

Phase I pharmacokinetic and pharmacodynamic study of pazopanib in children with soft tissue sarcoma and other refractory solid tumors: a children's oncology group phase I consortium report.

S. Baruchel, C. Ahern, J. Reid, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: A Children's Oncology Group phase I consortium study (ADVL0916)

C. Ahern, J. Reid, M. Ames, 2013, Pediatric blood & cancer.

A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011)

M. Loh, C. Ahern, J. Reid, 2015, Pediatric blood & cancer.

Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology Group.

Helen X. Chen, C. Ahern, P. Adamson, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I trial of Seneca Valley Virus (NTX‐010) in children with relapsed/refractory solid tumors: A report of the Children's Oncology Group

C. Rudin, C. Ahern, T. Cripe, 2015, Pediatric blood & cancer.

A Phase I Trial and Pharmacokinetic Study of Aflibercept (VEGF Trap) in Children with Refractory Solid Tumors: A Children's Oncology Group Phase I Consortium Report

S. Baruchel, A. Chen, C. Ahern, 2012, Clinical Cancer Research.

Pancreatic resection without routine intraperitoneal drainage.

C. Ahern, W. Fisher, F. Brunicardi, 2011, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Cross-species identification of a plasma microRNA signature for detection, therapeutic monitoring, and prognosis in osteosarcoma

L. Donehower, C. Ahern, S. Hilsenbeck, 2015, Cancer medicine.

A phase I trial and pharmacokinetic study of IMC-A12 in pediatric patients with relapsed/refractory solid tumors: A Children's Oncology Group Phase I Consortium study.

C. Ahern, C. Roberts, P. Adamson, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I trial of temsirolimus (TEM), irinotecan (IRN), and temozolomide (TMZ) in children with refractory solid tumors: A Children's Oncology Group study.

R. Norris, C. Ahern, R. Bagatell, 2012 .

Phase I study of pazopanib in children with relapsed or refractory solid tumors (ADVL0815): A Children's Oncology Group Phase I Consortium Trial.

S. Baruchel, C. Ahern, P. Adamson, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cost-Effectiveness Analysis of Mammography and Clinical Breast Examination Strategies: A Comparison with Current Guidelines

C. Ahern, Yu Shen, Charlotte Hsieh Ahern, 2009, Cancer Epidemiology Biomarkers & Prevention.

A phase I study of ruxolitinib in children with relapsed/refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group Phase I Consortium study (ADVL1011).

C. Ahern, P. Brown, K. Rabin, 2014 .

Phase I and Pharmacokinetic Study of Sunitinib in Pediatric Patients with Refractory Solid Tumors: A Children's Oncology Group Study

S. Baruchel, C. Ahern, P. Adamson, 2011, Clinical Cancer Research.